Neuroblastoma remains one of the most aggressive pediatric cancers, with limited treatment options for high-risk patients. In this work, it is presented a vascularized tumor-on-a-chip model designed to mimic the tumor microenvironment of neuroblastoma, integrating NB spheroids and supporting vasculogenesis. The microfluidic platform enables real-time observation of tumor-vascular interactions and response to anti-angiogenic treatments. It is demonstrated the system's applicability by evaluating the effect of cancer cells on vascular network formation alongside tumor behavior. This model represents a promising tool for personalized drug testing and preclinical studies.

Engineered 3D vascularized neuroblastoma tumor model in a fluidic chip for drug screening

CANDEO, FRANCESCA
2024/2025

Abstract

Neuroblastoma remains one of the most aggressive pediatric cancers, with limited treatment options for high-risk patients. In this work, it is presented a vascularized tumor-on-a-chip model designed to mimic the tumor microenvironment of neuroblastoma, integrating NB spheroids and supporting vasculogenesis. The microfluidic platform enables real-time observation of tumor-vascular interactions and response to anti-angiogenic treatments. It is demonstrated the system's applicability by evaluating the effect of cancer cells on vascular network formation alongside tumor behavior. This model represents a promising tool for personalized drug testing and preclinical studies.
2024
Engineered 3D vascularized neuroblastoma tumor model in a fluidic chip for drug screening
Neuroblastoma
Hydrogel
Vascularized
File in questo prodotto:
File Dimensione Formato  
Candeo_ Francesca.pdf

Accesso riservato

Dimensione 9.26 MB
Formato Adobe PDF
9.26 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/87612